A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)
Adjuvant Chemotherapy Versus Observation After Radiation With Concurrent Cisplatin of Cervical Cancer (With Pelvic or Para-aortic Node Involvement) :A Phase 3 Prospective Multi-institutional Randomised Controlled Trial
Sponsor: Sun Yat-sen University
A PHASE3 clinical study on Adjuvant Chemotherapy and Cervical Cancer, this trial is ongoing. The trial is conducted by Sun Yat-sen University and has accumulated 6 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Apr 2025 — Present [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE3
▶ Show 1 earlier version
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .